// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

WNT16 is up-regulated in the joint following inflammation

B.L. Thomas - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Agrin inhibits canonical WNT signalling through LRP4

S.E. Eldridge - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Agrin

Investigating diet-derived bioactives to maintain joint health and prevent osteoarthritis

R.K. Davidson - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Urocortin protects chondrocytes from acute trauma in articular cartilage

R.C. Jones - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

GsMTx4

Cartilage injury regulates inflammatory gene expression in part by suppressing cellular retinoic acid signaling

L. Zhu - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Appa compared against Meloxicam in canine OA

N.I. Larkins - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Famotidine

Safety, tolerability and pharmacokinetics of ONO-4474 in healthy subjects: a potential therapy for pain in osteoarthritis

P.G. Conaghan - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Defining abnormal cut-points for patellofemoral alignment and trochlear morphology and their relation to patellofemoral osteoarthritis: the framingham osteoarthritis study

E.M. Macri - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Association of osteoarthritis risk factors with knee and hip pain in a population-based sample of 2424 30–59 year olds in Denmark: a cross-sectional analysis.

J.A. van Tunen - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Investigation of relationships between hip bone mineral density and hip shape in adolescent and adult females

M. Frysz - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Risk of osteoarthritis and other long-term health outcomes in former elite english cricketers

M.E. Jones - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Osteoarthritis

N/A

Joint replacement and health-related quality of life amongst former rugby players

M.A. Davies - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The association of previous injury with joint pain, osteoarthritis, and joint replacement across all joints in former elite english cricketers

M.E. Jones - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

DNA methylation modulated by the osteoarthritis susceptibility locus marked by rs6094710 is associated with regulation of NCOA3 gene expression

A. Villalvilla - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Osteoarthritis

Decitabine

Epigenetic and transcriptional effects operate on the SUPT3H and RUNX2 genes residing at the chromosome 6p21.1 osteoarthritis susceptibility locus and correlate with the association signal

S.J. Rice - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Molecular phenotyping of patient chondrocytes reveals genes and pathways involved in osteoarthritis

J. Steinberg - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Cartilage Thickness, Denudation and Kl Grade: A Study of Medial Femorotibial Joints in 8,890 Knees from the Osteoarthritis Initiative

G. Guillard - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Attitudes, Beliefs and Common Practices of Hand Therapists for Base of Thumb Osteoarthritis in Australia (The ABC Thumb Study)

V. Duong - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

3D Knee Bone Shape Predisposes to ACL Rupture: Data from the Osteoarthritis Initiative and the Kanon Study

M.A. Bowes - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Clinimetrics of Ultrasonography in Osteoarthritis: A Systematic Literature Review

W. Oo - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved